Skip to main content
. 2010 Feb 22;101(6):1493–1500. doi: 10.1111/j.1349-7006.2010.01539.x

Table 1.

 Reversal of BCRP‐mediated drug resistances

RI50 values (μmol/L) for K562/BCRP
Sunitinib
MXR 0.10 ± 0.003
SN‐38 0.064 ± 0.004

Results are means ± SD of triplicate experiments. BCRP, breast cancer resistance protein; MXR, mitoxantrone; RI50, 50% reversal index; SN‐38, 7‐ethyl‐10‐hydroxycamptotecin.